Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 77Gastrointestinal 40Thoracic 22Genitourinary 15Head & Neck 14Gynecologic 7Lymphoid 4Other hematologic neoplasm 2Endocrine 2Plasma cell 1Other 1Dermatologic 1CNS 1

Conditions

Melanoma 2646Lymphoma, T-Cell, Cutaneous 479Skin Neoplasms 408Carcinoma, Non-Small-Cell Lung 377Mycosis Fungoides 330Neoplasms 319Keratosis, Actinic 300Sezary Syndrome 294Breast Neoplasms 285Neoplasm Metastasis 284Carcinoma, Renal Cell 280Lymphoma, Non-Hodgkin 276Lymphoma 263Carcinoma, Basal Cell 262Lymphoma, Large B-Cell, Diffuse 261Leukemia, Lymphocytic, Chronic, B-Cell 261Lymphoma, Follicular 259Hodgkin Disease 247Lymphoma, Mantle-Cell 245Lymphoma, B-Cell, Marginal Zone 245Precursor Cell Lymphoblastic Leukemia-Lymphoma 243Uveal Melanoma 234Burkitt Lymphoma 233Lymphoma, Large-Cell, Immunoblastic 223Colorectal Neoplasms 196Lymphoma, Large-Cell, Anaplastic 190Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 186Ovarian Neoplasms 181Squamous Cell Carcinoma of Head and Neck 180Lung Neoplasms 179

Interventions

Meloxicam 1Acetaminophen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Pain, Postoperative × Dermatologic × Clear all
NCT07200544 2025-12-15

Meloxicam in Mohs Micrographic Surgery

University of Oklahoma

Phase 4 Recruiting
300 enrolled
Dermatologic

Pain, Postoperative, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡